We are live on ! Find out more
KALA icon

KALA BIO
KALA

22 hedge funds and large institutions have $4.88M invested in KALA BIO in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 8 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

32% more capital invested

Capital invested by funds: $3.69M → $4.88M (+$1.19M)

5% more funds holding

Funds holding: 21 → 22 (+1)

0.07% more ownership

Funds ownership: 0.39% → 0.46% (+0.07%)

63% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 8

Holders
22
Holders Change
+1
Holders Change %
+4.76%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
8
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UOC
UBS O'Connor
Illinois
+$539K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$104K
3
Citadel Advisors
Citadel Advisors
Florida
+$99.9K
4
UBS Group
UBS Group
Switzerland
+$11.1K
5
Millennium Management
Millennium Management
New York
+$5.57K

Top Sellers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
-$20.4K
2
Renaissance Technologies
Renaissance Technologies
New York
-$20.1K
3
Bank of America
Bank of America
North Carolina
-$18.6K
4
KOCAA
Knights of Columbus Asset Advisors
Connecticut
-$18.2K
5
Morgan Stanley
Morgan Stanley
New York
-$14.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
BBA
1
Baker Bros. Advisors
New York
$2.12M – – –
Millennium Management
2
Millennium Management
New York
$1.05M +$5.57K +15 +0.6%
UOC
3
UBS O'Connor
Illinois
$569K +$539K +1,451 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$335K +$104K +279 +50%
BlackRock
5
BlackRock
New York
$217K -$743 -2 -0.4%
BOTOTLSJU
6
Board of Trustees of The Leland Stanford Junior University
California
$168K – – –
Geode Capital Management
7
Geode Capital Management
Massachusetts
$142K -$2.23K -6 -2%
Citadel Advisors
8
Citadel Advisors
Florida
$106K +$99.9K +269 New
Renaissance Technologies
9
Renaissance Technologies
New York
$91K -$20.1K -54 -19%
KOCAA
10
Knights of Columbus Asset Advisors
Connecticut
$19.3K -$18.2K -49 -51%
UBS Group
11
UBS Group
Switzerland
$17.3K +$11.1K +30 +214%
TRCT
12
Tower Research Capital (TRC)
New York
$12.9K -$20.4K -55 -63%
Morgan Stanley
13
Morgan Stanley
New York
$10.8K -$14.1K -38 -58%
C
14
Covestor
United Kingdom
$8K -$1.49K -4 -16%
BCV
15
Banque Cantonale Vaudoise
Switzerland
$6K – – –
CLOS
16
Compagnie Lombard Odier SCmA
Switzerland
$3.14K – – –
Citigroup
17
Citigroup
New York
$2.32K – – –
Carson Wealth (CWM LLC)
18
Carson Wealth (CWM LLC)
Nebraska
$2K – – –
Osaic Holdings
19
Osaic Holdings
Arizona
$1.92K – – –
SPIA
20
Steward Partners Investment Advisory
New York
$956 – – –
Bank of America
21
Bank of America
North Carolina
$885 -$18.6K -50 -96%
JP Morgan Chase
22
JP Morgan Chase
New York
$274 – – –
OPTFSNA
23
Old Point Trust & Financial Services N A
Virginia
$159 – – –
PNC Financial Services Group
24
PNC Financial Services Group
Pennsylvania
$159 – – –
Wells Fargo
25
Wells Fargo
California
$143 – – –
1
2

KALA Hedge Fund Activity: Q1 2024 in Review

22 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q1 2024, worth a combined $4.88M — up 32% from $3.69M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new KALA positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 8 trimmed.

The largest buyer was UBS O'Connor, opening a new position worth an estimated $539K. The largest seller was Tower Research Capital (TRC), cutting an estimated $20.4K.

  • 22 institutional investors held KALA BIO (KALA) as of Q1 2024, up from 21 in Q4 2023.
  • Funds reported $4.88M of KALA BIO stock for Q1 2024, up 32% quarter-over-quarter.
  • 2 funds opened new KALA BIO positions in Q1 2024 and 1 closed out, a net change of +1 holder.
  • The largest KALA BIO buyer in Q1 2024 was UBS O'Connor, an estimated $539K added.
  • The largest KALA BIO seller in Q1 2024 was Tower Research Capital (TRC), an estimated $20.4K sold.

Based on aggregated 13F filings for Q1 2024.